Search research articles
Contact Us
Filters
Showing results (81-90 of 86) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 86 results.
Molecular Cancer Therapeutics
|
February 13, 2023
Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 18, 2022
Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo
Cassandra L Gorsuch, Paige Nemec, Mei Yu, et al.
Biorxiv : the Preprint Server for Biology
|
October 3, 2025
RHO1-2 meganuclease gene editing targets human P23H rhodopsin-induced retinitis pigmentosa to rejuvenate rods and maintain cones
Archana Jalligampala, Jacob M Young, Jack Feist, et al.
Journal of Critical Care
|
January 24, 2026
Long-term outcomes of abnormal global longitudinal left ventricular strain during sepsis: A retrospective cohort study
Ivan Huespe, Fernando A Sosa, Anek Jena, et al.
European Urology
|
January 30, 2023
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study
Noah M Hahn, Michael A O'Donnell, Jason A Efstathiou, et al.
Nature
|
March 25, 2011
Inclusive fitness theory and eusociality
Patrick Abbot, Jun Abe, John Alcock, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 86) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 86 results.
Molecular Cancer Therapeutics
|
February 13, 2023
Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 18, 2022
Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo
Cassandra L Gorsuch, Paige Nemec, Mei Yu, et al.
Biorxiv : the Preprint Server for Biology
|
October 3, 2025
RHO1-2 meganuclease gene editing targets human P23H rhodopsin-induced retinitis pigmentosa to rejuvenate rods and maintain cones
Archana Jalligampala, Jacob M Young, Jack Feist, et al.
Journal of Critical Care
|
January 24, 2026
Long-term outcomes of abnormal global longitudinal left ventricular strain during sepsis: A retrospective cohort study
Ivan Huespe, Fernando A Sosa, Anek Jena, et al.
European Urology
|
January 30, 2023
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study
Noah M Hahn, Michael A O'Donnell, Jason A Efstathiou, et al.
Nature
|
March 25, 2011
Inclusive fitness theory and eusociality
Patrick Abbot, Jun Abe, John Alcock, et al.
Page
of 9